bpc 157 stable in gastric juice Pentadecapeptide and Wound Healing BPC-157 Peptide Therapy | Regenerative
Description
roughly 50-98 % of an administered dose is renally excreted unmetabolized, underscoring the low intrinsic toxicity
Although not a direct drug-drug interaction, increased GH/IGF-1 levels may raise blood glucose
MOTS-c has a 24 hour half-life with effects lasting 1224 hours via AMPK phosphorylation
Shaking introduces air bubbles and can cause foaming, which denatures surface-exposed peptide chains
Since IGFBPs normally sequester most circulating IGF-1, this escape from binding protein control creates much higher free (bioactive) concentrations at the injection site
